Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 937M | 897M | 1.2B | 1.1B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 168M | 199M | 184M | 124M |
Operating income | 347M | 266M | 523M | 552M |
Non operating interest income | ||||
Income | 42M | 61M | 40M | 37M |
Expense | 585M | 625M | 678M | 685M |
Other income expense | — | — | — | — |
Pretax income | 769M | -102M | 1.7B | -55M |
Tax provision | 5M | -1M | 12M | -22M |
Net income | 764M | -101M | 1.6B | -33M |
Basic EPS | 4.8 | -0.9 | 10.2 | -0.3 |
Diluted EPS | 4.8 | -0.9 | 10.2 | -0.3 |
Basic average shares | 158.9M | 158.9M | 158.9M | 158.9M |
Diluted average shares | 158.9M | 158.9M | 158.9M | 158.9M |
EBITDA | 990M | 818M | 1.2B | 927M |
Net income from continuing op. | 1.2B | 521M | 2.3B | 633M |
Minority interests | -2M | -40M | -26M | -22M |
Preferred stock dividends | 0 | 0 | 0 | 0 |